These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16089503)

  • 41. Binding of longer peptides to the H-2Kb heterodimer is restricted to peptides extended at their C terminus: refinement of the inherent MHC class I peptide binding criteria.
    Hörig H; Young AC; Papadopoulos NJ; DiLorenzo TP; Nathenson SG
    J Immunol; 1999 Oct; 163(8):4434-41. PubMed ID: 10510385
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.
    Burmeister WP; Gastinel LN; Simister NE; Blum ML; Bjorkman PJ
    Nature; 1994 Nov; 372(6504):336-43. PubMed ID: 7969491
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural killer cell recognition of HLA class I molecules.
    Brooks AG; Boyington JC; Sun PD
    Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure and function of the non-classical major histocompatibility complex molecule MR1.
    Krovi SH; Gapin L
    Immunogenetics; 2016 Aug; 68(8):549-59. PubMed ID: 27448212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation.
    Young AC; Nathenson SG; Sacchettini JC
    FASEB J; 1995 Jan; 9(1):26-36. PubMed ID: 7821756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crystal structure of human ZAG, a fat-depleting factor related to MHC molecules.
    Sánchez LM; Chirino AJ; Bjorkman Pj
    Science; 1999 Mar; 283(5409):1914-9. PubMed ID: 10206894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins.
    Reich Z; Altman JD; Boniface JJ; Lyons DS; Kozono H; Ogg G; Morgan C; Davis MM
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2495-500. PubMed ID: 9122223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic characteristics of a peptide-binding groove of human HLA-A2 class I MHC molecules: normal mode analysis of the antigen peptide-class I MHC complex.
    Nojima H; Takeda-Shitaka M; Kurihara Y; Adachi M; Yoneda S; Kamiya K; Umeyama H
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1209-14. PubMed ID: 12237537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition.
    Bluestone JA; Jameson S; Miller S; Dick R
    J Exp Med; 1992 Dec; 176(6):1757-61. PubMed ID: 1460430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Class I major histocompatibility complexes loaded by a periodate trigger.
    Rodenko B; Toebes M; Celie PH; Perrakis A; Schumacher TN; Ovaa H
    J Am Chem Soc; 2009 Sep; 131(34):12305-13. PubMed ID: 19655751
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular immunology of allograft rejection: insights from MHC mutants and crystal structure.
    DiSesa VJ
    J Heart Lung Transplant; 1991; 10(1 Pt 1):111-6. PubMed ID: 2007162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of spatially coexpressed families of type-2 vomeronasal receptors in rodents.
    Francia S; Silvotti L; Ghirardi F; Catzeflis F; Percudani R; Tirindelli R
    Genome Biol Evol; 2014 Dec; 7(1):272-85. PubMed ID: 25539725
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
    Braud V; Jones EY; McMichael A
    Eur J Immunol; 1997 May; 27(5):1164-9. PubMed ID: 9174606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Statistical deconvolution of enthalpic energetic contributions to MHC-peptide binding affinity.
    Davies MN; Hattotuwagama CK; Moss DS; Drew MG; Flower DR
    BMC Struct Biol; 2006 Mar; 6():5. PubMed ID: 16549002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystal structure of Qa-1a with bound Qa-1 determinant modifier peptide.
    Ying G; Wang J; Kumar V; Zajonc DM
    PLoS One; 2017; 12(8):e0182296. PubMed ID: 28767728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An Invariant Arginine in Common with MHC Class II Allows Extension at the C-Terminal End of Peptides Bound to Chicken MHC Class I.
    Xiao J; Xiang W; Zhang Y; Peng W; Zhao M; Niu L; Chai Y; Qi J; Wang F; Qi P; Pan C; Han L; Wang M; Kaufman J; Gao GF; Liu WJ
    J Immunol; 2018 Nov; 201(10):3084-3095. PubMed ID: 30341185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ligand Design for Specific MHC Class I Molecules on the Cell Surface.
    Sun X; Tokunaga R; Nagai Y; Miyahara R; Kishimura A; Kawakami S; Katayama Y; Mori T
    Biochemistry; 2020 Dec; 59(49):4646-4653. PubMed ID: 33252220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal structure of mouse H2-M.
    Fremont DH; Crawford F; Marrack P; Hendrickson WA; Kappler J
    Immunity; 1998 Sep; 9(3):385-93. PubMed ID: 9768758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystal structure of a non-canonical low-affinity peptide complexed with MHC class I: a new approach for vaccine design.
    Apostolopoulos V; Yu M; Corper AL; Teyton L; Pietersz GA; McKenzie IF; Wilson IA; Plebanski M
    J Mol Biol; 2002 May; 318(5):1293-305. PubMed ID: 12083518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.